Your browser doesn't support javascript.
loading
Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial.
Migden, Michael R; Guminski, Alexander; Gutzmer, Ralf; Dirix, Luc; Lewis, Karl D; Combemale, Patrick; Herd, Robert M; Kudchadkar, Ragini; Trefzer, Uwe; Gogov, Sven; Pallaud, Celine; Yi, Tingting; Mone, Manisha; Kaatz, Martin; Loquai, Carmen; Stratigos, Alexander J; Schulze, Hans-Joachim; Plummer, Ruth; Chang, Anne Lynn S; Cornélis, Frank; Lear, John T; Sellami, Dalila; Dummer, Reinhard.
Afiliação
  • Migden MR; Mohs Surgery Center, Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: mrmigden@mdanderson.org.
  • Guminski A; Department of Medical Oncology, Royal North Shore Hospital, St Leonards, NSW, Australia.
  • Gutzmer R; Department of Dermatology and Allergy, Medizinische Hochschule Hannover, Hannover, Germany.
  • Dirix L; Department of Medical Oncology, Sint-Augustinus Ziekenhuis, Antwerp, Belgium.
  • Lewis KD; Division of Medical Oncology, University of Colorado School of Medicine, Aurora, CO, USA.
  • Combemale P; Department of Onco-Dermatology, Anticancer Institute, Lyon, France.
  • Herd RM; Department of Dermatology, Glasgow Royal Infirmary, Glasgow, UK.
  • Kudchadkar R; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA.
  • Trefzer U; Dermatologikum Berlin, Berlin, Germany.
  • Gogov S; Oncology Clinical Development, Novartis Pharma, Basel, Switzerland.
  • Pallaud C; Oncology Clinical Development, Novartis Pharma, Basel, Switzerland.
  • Yi T; Biometrics and Data Management, Oncology Business Unit, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Mone M; Oncology Clinical Development, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Kaatz M; Department of Dermatology and Allergology, University Hospital Jena, Jena, Germany; SRH Wald-Klinikum Gera, Gera, Germany.
  • Loquai C; Deparment of Dermatology, University Medical Center Mainz, Mainz, Germany.
  • Stratigos AJ; Deparment of Dermatology, Andreas Sygros Hospital, University of Athens, Athens, Greece.
  • Schulze HJ; Fachklinik Hornheide, Münster, Germany.
  • Plummer R; Northern Centre for Cancer Care, Freeman Hospital, Newcastle upon Tyne, UK.
  • Chang AL; Deparment of Dermatology, Stanford University School of Medicine, Redwood City, CA, USA.
  • Cornélis F; Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
  • Lear JT; Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
  • Sellami D; Oncology Global Development, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Dummer R; Universitätsspital Zürich-Skin Cancer Center University Hospital, Zürich, Switzerland.
Lancet Oncol ; 16(6): 716-28, 2015 Jun.
Article em En | MEDLINE | ID: mdl-25981810
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridinas / Neoplasias Cutâneas / Compostos de Bifenilo / Carcinoma Basocelular / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridinas / Neoplasias Cutâneas / Compostos de Bifenilo / Carcinoma Basocelular / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article